Please login to the form below
BCG vaccine
This page shows the latest BCG vaccine news and features for those working in and with pharma, biotech and healthcare.
UK scientists begin testing BCG vaccine for severe COVID-19 protection
The BCG vaccine, originally developed in 1921, is traditionally used to protect against tuberculosis although it is no longer routinely administered in the UK. ... In South Africa, the BCG vaccine reduced respiratory tract infections by 73% in adolescents
Latest news
-
GSK licenses its tuberculosis vaccine to Gates MRI
Last year, a phase 2b trial of M72/AS01E showed that the vaccine had around 50% efficacy in preventing pulmonary TB disease in adolescents and adults, something which the current BCG ... BCG has been used for decades as a TB vaccine and while it has
-
Keytruda claims first place in bladder cancer race
Keytruda (pembrolizumab) has been cleared by the FDA for the treatment of patients with high-risk NMIBC who don’t respond to Merck’s TICE Bacille Calmette-Guérin (BCG) vaccine, used ... Merck. Around 30% to 40% of NMIBC patients don’t respond to
-
FDA panel clears Keytruda for hard-to-treat bladder cancer
NMIBC is a low-grade tumour found in the tissue lining the bladder, and is currently usually treated with Merck’s TICE Bacille Calmette-Guérin (BCG) vaccine, intended to boost the ... The patients had been treated a median of 12 times with BCG but
-
GSK's pivotal TB vaccine could prevent millions of deaths
GlaxoSmithKline has announced that its IAVI-partnered experimental tuberculosis (TB) vaccine candidate significantly reduced the occurrence of pulmonary tuberculosis disease. ... the only available vaccine, BCG, not providing a proven and consistent
-
PD1 drugs could end 'decades of silence' in bladder cancer therapy
the patient's own immune system to fight the disease - ties in with the treatment of non-muscle invasive bladder cancer with the BCG vaccine.
More from news
Approximately 1 fully matching, plus 9 partially matching documents found.
Latest Intelligence
-
ASEAN: Domestic vaccines manufacturers
One of GAVI's strategic objectives is shaping the vaccine marketplace. By 2011, 5 out of 10 vaccines manufacturers that were awarded contracts were based in emerging markets. ... Thailand – a bold vision for growth. Thailand has held vaccines
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- bluebird bio reveals plans to launch two gene therapies
- Sanofi halts recruitment for trials assessing MS treatment
- Eli Lilly to make bebtelovimab commercially available to US states from August
- The patient voice – the value of patient-reported outcomes in HTA
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- ONS records a continued fall in UK COVID-19 infections
- Powering Rapid Cognitive Analysis with AI
- How the Royal Society’s EiR programme can help to drive UK innovation
- BMS and 2seventy bio announce positive results for multiple myeloma treatment
- Roche and Cend Therapeutics to evaluate pancreatic cancer combination therapy
- Aqilion initiates phase 1 clinical trial for chronic inflammatory diseases
- JCVI publishes statement on London polio vaccination strategy
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- AstraZeneca’s Alexion agrees on $775m settlement with Chugai for Ultomiris
- EMA backs adjuvant use of Roche’s breast cancer ADC Kadcyla
- FDA approves Coherus’ Cimerli as biosimilar interchangeable with Lucentis for all five indications
- Gilead Sciences set to acquire MiroBio in deal worth over $400m
PMHub
Cegedim Health Data
Cegedim Health Data provides Real World Data and Evidence services to enable advancements in patient outcomes. With a data history...
